Global Glycated Hemoglobin Testing Market Size, Trends & Analysis - Forecasts To 2026

1. Global Glycated Hemoglobin Testing Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Laboratory HbA1c Testing Products, Point of Care (POC) HbA1c Testing Products), By Technology (Chromatography, Others), By End User (Hospitals, Physical Examination Institution, Research Institutions, Others), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis Glycated Hemoglobin Testing Market Insights The global glycated hemoglobin testing market is estimated to witness a high CAGR during the forecast period (2019-2026). Growing geriatric population, increasing diabetic patients, and growing technological advancements in diagnosing are some of the major factors driving the glycated hemoglobin testing market during the forecast period. This test method is used to measure an average plasma glucose concentration in the blood along with measurement of the volume of glycosylated hemoglobin. Increasing awareness of POC HbA1c testing is also expected to drive market growth in developing countries such as India, Singapore, and Brazil among others. Growing demand for rapid POCT, and diagnostic methods to detect diabetes is expected to propel the market during the forecast period. However, availability of substitutes, stringent environment norms, high cost of glycated hemoglobin testing devices are likely to hamper the market growth during the forecast period. Request a free sample copy of the report @https://www.globalmarketestimates.com/report- summary.php?report_id=1654&report_name=global-glycated- hemoglobin-testing-market

2. Glycated Hemoglobin Testing Market: By Product Type On the basis of product type, the global glycated hemoglobin testing market is segmented into laboratory HbA1c testing products, and point-of-care (POC) HbA1c testing products. The laboratory HbA1c testing products segment is expected to occupy the largest market share in terms of revenue during the forecast period. This test is used to check control in diabetes mellitus. The point of care (POC) HbA1c testing product segment is expected to grow at the highest CAGR in terms of revenue during the forecast period. Moreover, growing demand of point-of-care testing is recognized as the leading testing method for testing glycated hemoglobin. Glycated Hemoglobin Testing Market: By End User On the basis of end user, the global glycated hemoglobin testing market is segmented into hospitals, physical examination institution, and research institutions among others. The hospitals segment is expected to hold the largest market share during the forecast period. Growing number of hospitals along with increasing government investments in renovating hospitals is driving glycated hemoglobin testing market during the forecast period. The physical examination institution segment is expected to grow at the highest CAGR from 2019 to 2026. Glycated Hemoglobin Market: By Region On the basis of region, the market for glycated hemoglobin is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America. North America is expected to witness considerable growth in the glycated hemoglobin market during the forecast period. Growing population, increased awareness of diseases and high investment on medical testing devices is expected to drive the market growth in the North America region. Increasing prevalence of diabetes in the U.S. and Canada has resulted in a demand for glucose monitoring due to unhealthy eating habits and safety. The Asia-Pacific region is expected to grow at a high CAGR during the forecast period. Glycated hemoglobin Market: End Use Landscape The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are Medline Plus, Mayo Clinic, and Experian among others. Glycated hemoglobin Market: Vendor Landscape The report contains a chapter dedicated to vendors operating in the glycated hemoglobin market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these

3. insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Glycated hemoglobin Market Share & Competitor Analysis Some of the key players operating in the Glycated hemoglobin market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Alere Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Bayer AG, Randox Laboratories Ltd., Tosoh Corporation, ARKRAY, Inc., and A.Menarini Diagnostics Ltd. among others. In January 2019, Abbott Laboratories signed an agreement to acquire Cephea Valve Technologies, Inc. The company is engaged in providing catheter delivered mitral valve regurgitation products/heart In August 2019, Bayer AG successfully acquired BlueRock Therapeutics for USD 1 billion. Bayer AG is recognized as the leading multinational pharmaceutical and life sciences company Browse the report @https://www.globalmarketestimates.com/report- summary.php?report_id=1654&report_name=global-glycated- hemoglobin-testing-market • •